Daily non-political popular news in brief.

A research of the UGR shows the genetic predisposition to develop alcohol abuse

12-18-2007 · EurekAlert!

The research reveals that a subject's brain with low beta-endorphin levels becomes accustomed to the presence of an exogenous surplus, diminishing its own supply and triggering dependence on an external source -- in this case, alcohol.

Keywords: research, ugr, shows, genetic, predisposition, develop, alcohol, abuse, show

« Previous | Next »

Similar news on "A research of the UGR shows the genetic predisposition to develop alcohol abuse":

Some smokers have genetic predisposition to develop COPD, research shows
07-11-2007 · EurekAlert!
Some people have a genetic variation that makes them more susceptible to chronic obstructive pulmonary disease if they smoke tobacco, according to new research from Wake Forest University School of Medicine and colleagues.
Similar news · Read more »
Plays promote prevention of drug abuse
04-04-2007 · EurekAlert!
A new study finds that theatrical drama is an educational tool in the fight against drug addiction and abuse. Research published today in Substance Abuse Treatment, Prevention and Policy, shows that after watching the play "Tunnels" -- a series of six vignettes depicting the effects of alcohol and drug abuse -- over half of the audience left the theatre wanting to get involved directly in drug and alcohol prevention in their homes and communities.
Similar news · Read more »
Mexican Americans carrying haplotype H6 of the CYP2E1 gene have a greater risk of alcoholism
11-26-2007 · EurekAlert!
Mexican Americans make up 66 percent of the US Hispanic population and, when compared to other ethnic groups, show high rates of heavy drinking and alcohol-related problems. First-of-its-kind research that examines haplotypes -- clusters of genetic polymorphisms -- of the CYP2E1 gene among a Mexican-American population has found that carrying haplotype H6 may enhance susceptibility to developing alcoholism.
Similar news · Read more »
Breakthrough in understanding type-2 diabetes as key genes identified
02-14-2007 · EurekAlert!
The most important genes associated with a risk of developing type-2 diabetes have been identified, scientists report today in a new study. The research, published online in Nature, is the first time the genetic makeup of any disease has been mapped in such detail. It should enable scientists to develop a genetic test to show an individual their likelihood of developing diabetes mellitus type 2, commonly known as type-2 diabetes.
Similar news · Read more »
Advance in understanding of blood pressure gene could lead to new treatments
02-04-2007 · EurekAlert!
Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
Similar news · Read more »
There's no scent like home
01-08-2007 · EurekAlert!
New research from MBL scientists and their colleagues shows that some fish larvae can discriminate odors in ocean currents and use scent to return to the reefs where they were born. The olfactory imprinting of natal reefs sheds light on how such a wide diversity of species arose. The homing behavior of reef fishes, the researchers contend, could support population isolation and genetic divergence that may ultimately lead to the formation of new species.
Similar news · Read more »
Clues to gene expression in cystic fibrosis will guide research
03-28-2007 · EurekAlert!
Genetics tests could help provide cystic fibrosis (CF) patients with targeted treatment in future, pilot study authors suggest. Results from a French clinical trial published today in BMC Medicine show how a small percentage of CF sufferers with a rare genetic stop mutation responded positively to gentamicin treatment.
Similar news · Read more »
No 'smoking' gun -- Research indicates teen marijuana use does not predict drug, alcohol abuse
12-04-2006 · EurekAlert!
Marijuana is not a "gateway" drug that predicts or eventually leads to substance abuse, suggests a 12-year University of Pittsburgh study. The study, which found that young men who chose to initiate their drug use with marijuana were no more likely to go on to abuse drugs or alcohol than those who smoked or drank first, calls into question the long-held belief that has shaped prevention efforts and governmental policy for six decades.
Similar news · Read more »
Alcohol abuse is in the genes
06-29-2007 · EurekAlert!
Researchers state that "alcohol-abuse prevention must consist of locating and identifying genetically predisposed subjects." The research reveals that a subject's brain with low beta-endorphin levels becomes accustomed to the presence of an exogenous surplus, diminishing its own supply and triggering dependence on an external source -- in this case, alcohol.
Similar news · Read more »
The G allele of the mu-opioid receptor gene is linked to craving for alcohol
01-03-2007 · EurekAlert!
Alcohol-use disorders have a significant genetic component to their development. New findings show that heavy drinkers with the G allele of the A118G polymorphism of the mu-opioid receptor gene have greater cravings after alcohol exposure than heavy drinkers homozygous for the A allele. Individuals with the G allele may have more problems resisting the urge to drink.
Similar news · Read more »